Status:
COMPLETED
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
A novel human coronavirus, named SevereAcute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), emerged in China, in late 2019, and is now spreading quickly causing a pandemic. It is usually responsible...
Detailed Description
A novel human coronavirus, named SevereAcute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), emerged in China, in late 2019, and is now spreading quickly causing a pandemic. It is usually responsible...
Eligibility Criteria
Inclusion
- Any pregnant woman giving birth or having a miscarriage after 15 weeks.
- Major patient
Exclusion
- Patients not speaking French and not accompanied by a translator
- Patients under curatorship / guardianship
- Refusal to participate in research
Key Trial Info
Start Date :
May 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
2446 Patients enrolled
Trial Details
Trial ID
NCT04355234
Start Date
May 4 2020
End Date
August 31 2021
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tsastaris Vassillis
Paris, France